Biontech
BioNTech is developing two bispecific antibody checkpoint immunomodulators BNT311 and BNT312 as part of a 5050 collaboration with…
Thursday, March 31, 2022
Edit
Showing posts with label Biontech. Show all posts
Showing posts with label Biontech. Show all posts
Subscribe to:
Posts (Atom)